中國衛生集團(00673.HK)擬發行7億股新股及按“10供3”基準供股籌資 5月23日起復牌
格隆匯5月23日丨中國衛生集團(00673.HK)發佈公告,公司擬進行認購事項及供股,以應對集團的財務挑戰及解決資本需求,以支持持續運營及未來發展。2025年4月30日,公司訂立認購協議A、認購協議B及認購協議C,內容有關按認購價每股認購股份0.1港元向認購人A(即Ample Colour Limited,由應偉先生全資擁有)、認購人B(即Perfect Link Group Limited,由應偉先生的女兒應任斯女士全資擁有)及認購人C(即鄔琳玲女士)分別發行及認購5億股新股份、1億股新股份及1億股新股份(總計7億股新股份)。
根據認購協議,認購股份將與供股股份同時予以配發及發行。爲免生疑問,認購股份將無權參與供股。總計數目7億股認購股份佔(i)於本公佈日期已發行股份總數的約142.4%;及(ii)緊隨認購事項及供股完成後經配發及發行認購股份及供股股份擴大後的已發行股份總數的約52.3%。
公司建議按於記錄日期合資格股東每持有10股股份獲發3股供股股份的基準以發行價每股供股股份0.1港元進行供股,以籌集總金額介乎約1470萬港元至約1500萬港元。2025年4月30日公司與包銷商(即Treasure Wagon Limited,由主席及執行董事張凡先生全資擁有)就供股訂立包銷協議,據此,包銷商同意根據包銷協議所載條款並在其條件規限下認購未獲承購供股股份,即並無獲配售代理成功配售的所有未獲認購供股股份。
經獨立董事委員會批準,紅日資本有限公司已獲委任爲獨立財務顧問,以就此向獨立董事委員會及獨立股東提供意見。公司股份已自2025年5月2日上午九時正起暫停買賣,以待刊發本公佈。於刊發本公佈後,公司已申請自2025年5月23日上午九時正起恢復股份買賣。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.